Inoviq Ltd has released a press release.
IIQ Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Inoviq
- IIQ Appendix 4C & Quarterly Activities Report - June 2022
- Positive SubB2M IHC Results for Melanoma
- hTERT US Patent Granted
- INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
- SubB2M US Patent Grant and Program Update
Later from Inoviq
- 2022 Annual Report and update on results
- INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
- Receipt of R&D Tax Incentive Refund
- Canadian Patent Granted for BARD1 Technology
- IIQ Appendix 4C & Quarterly Activities Report-September 2022
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq